Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic TherapiesShiven B. Patel, Neeraj Agarwal, Archana M. Agarwal et al.|Clinical Genitourinary Cancer|2015Cited by 15
Assessment of time from cytoreductive nephrectomy (CN) to initiation of targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC).Winston Vuong, Sumanta Kumar Pal, Mark Chang et al.|Journal of Clinical Oncology|2014Cited by 0